This review summarises important pharmacological and clinical characteristics of treatment with crisaborole
(StaquisTM), a paraffin-based ointment indicated for topical treatment of mild to moderate atopic dermatitis in patients 2 years of age and older.
It also provides commentary from Associate Professor John Su, Director of Dermatology at Eastern Health in Melbourne and an honorary reseacher at the Murdoch Children's Research Institute.
Please login below to download this issue (PDF)